J2281 Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg
Short descriptor: Inj moxifloxacin (fres kabi)
Look up J2281 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
J2281 is the HCPCS Level II code for Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2024-07-01
- 2026 Maintenance
- No change this year
Drug Details
- Drug / Substance
- moxifloxacin, not therapeutically equivalent to j2280
- Dose / Unit
- 100 mg
- Route
- Injection
See the full HCPCS Table of Drugs (J-codes).
References
Cite This Page
Reference J2281 with the canonical source and edition:
J2281 — Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J2281
Canonical URL: https://icd10codingpro.com/hcpcs-codes/J2281